HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead

Personalized Medicine

Oct 3

Written by Matthijs Versteegh

personalized medicine

Matthijs Versteegh

Benefits of sphingosine-1-phosphate receptor modulators in relapsing MS estimated with a treatment sequence model

Budget impact and transferability of cost–effectiveness of DPYD testing in metastatic breast cancer in three health systems